IRIS
MANCINI, NICASIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.784
NA - Nord America 5.074
AS - Asia 4.281
SA - Sud America 1.107
Continente sconosciuto - Info sul continente non disponibili 344
AF - Africa 106
OC - Oceania 9
Totale 16.705
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.720
RU - Federazione Russa 2.793
SG - Singapore 1.431
IT - Italia 1.385
CN - Cina 1.366
BR - Brasile 895
SE - Svezia 613
HK - Hong Kong 545
VN - Vietnam 419
FR - Francia 224
DE - Germania 203
CA - Canada 174
GB - Regno Unito 132
IN - India 109
BD - Bangladesh 97
FI - Finlandia 92
NL - Olanda 81
AR - Argentina 77
MX - Messico 64
PL - Polonia 51
AT - Austria 47
IE - Irlanda 46
EC - Ecuador 44
JP - Giappone 44
ZA - Sudafrica 42
ES - Italia 36
TR - Turchia 36
IQ - Iraq 34
ID - Indonesia 32
CO - Colombia 29
CR - Costa Rica 23
SA - Arabia Saudita 21
JM - Giamaica 20
UZ - Uzbekistan 20
TT - Trinidad e Tobago 17
PH - Filippine 15
PK - Pakistan 15
LT - Lituania 14
PY - Paraguay 14
CL - Cile 13
MA - Marocco 12
MY - Malesia 12
PE - Perù 12
VE - Venezuela 12
AE - Emirati Arabi Uniti 11
RO - Romania 11
UA - Ucraina 11
HN - Honduras 10
SV - El Salvador 10
TN - Tunisia 10
IR - Iran 9
JO - Giordania 9
NI - Nicaragua 9
EG - Egitto 8
AU - Australia 7
BE - Belgio 7
DZ - Algeria 7
NP - Nepal 7
AZ - Azerbaigian 6
KE - Kenya 6
UY - Uruguay 6
DK - Danimarca 5
GT - Guatemala 5
HU - Ungheria 5
IL - Israele 5
KZ - Kazakistan 5
PR - Porto Rico 5
RS - Serbia 5
DO - Repubblica Dominicana 4
GA - Gabon 4
GD - Grenada 4
HR - Croazia 4
TH - Thailandia 4
AL - Albania 3
BH - Bahrain 3
CH - Svizzera 3
CM - Camerun 3
CW - ???statistics.table.value.countryCode.CW??? 3
GY - Guiana 3
KH - Cambogia 3
KR - Corea 3
MU - Mauritius 3
PA - Panama 3
PS - Palestinian Territory 3
TW - Taiwan 3
A1 - Anonimo 2
AM - Armenia 2
BO - Bolivia 2
BS - Bahamas 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
EU - Europa 2
KG - Kirghizistan 2
KW - Kuwait 2
LB - Libano 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
QA - Qatar 2
Totale 16.346
Salva come PNG Salva come JPEG
Città #
Ashburn 752
Singapore 633
Moscow 606
Dallas 561
Hong Kong 541
San Jose 493
Milan 390
Shanghai 291
Beijing 203
Council Bluffs 202
Hefei 187
New York 172
Ho Chi Minh City 165
Lauterbourg 162
Princeton 154
Lawrence 150
Los Angeles 113
São Paulo 91
Phoenix 89
Hanoi 85
Rome 84
Santa Clara 82
Munich 59
Helsinki 58
Warsaw 46
Montreal 45
Chennai 43
Orem 43
Turin 43
Nuremberg 42
Atlanta 40
Florence 37
Stockholm 37
Tokyo 35
Dublin 34
London 34
Toronto 34
Brescia 33
Denver 33
Miano 33
Johannesburg 32
Boardman 31
Brooklyn 31
Bologna 29
Mexico City 28
Houston 27
Poplar 27
Chicago 26
Seattle 26
Belo Horizonte 24
Turku 24
Boston 22
Cesano Boscone 22
Guangzhou 21
Naples 21
Frankfurt am Main 20
Rio de Janeiro 20
Vienna 20
Haiphong 19
Amsterdam 18
Falkenstein 18
San José 18
Shenzhen 18
The Dalles 18
Tashkent 17
Campinas 15
Brasília 14
Catania 14
Da Nang 14
Genoa 14
Manchester 14
Porto Alegre 14
San Francisco 14
Washington 14
Columbus 13
Curitiba 13
Hangzhou 13
Omaha 13
Pune 13
Ankara 12
Guayaquil 12
Kingston 12
Mumbai 12
Salvador 12
Tianjin 12
Baghdad 11
Biên Hòa 11
Quito 11
Sorocaba 11
Guarulhos 10
Bogotá 9
Calgary 9
Chaguanas 9
Charlotte 9
Dhaka 9
Lappeenranta 9
Managua 9
Miami 9
Paris 9
The Bronx 9
Totale 7.920
Salva come PNG Salva come JPEG
Nome #
A modified Frosch approach for posterior tibial plateau fractures: Technical note and case series 779
A Human Stem Cell-Derived Neurosensory–Epithelial Circuitry on a Chip to Model Herpes Simplex Virus Reactivation 244
Beauveria bassiana Keratitis: A Case Series and Review of Literature 197
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 195
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models 185
Levofloxacin prophylaxis vs no prophylaxis in neutropenic patients within an endemic country for carbapenem-resistant GNB 158
Biobanking for COVID-19 research 157
Nanopore ReCappable sequencing maps SARS-CoV-2 5' capping sites and provides new insights into the structure of sgRNAs 157
The interferon landscape along the respiratory tract impacts the severity of COVID-19 153
Answer to Photo Quiz: Scolecobasidium sp 144
Antibody Titer Kinetics and SARS-CoV-2 Infections Six Months after Administration with the BNT162b2 Vaccine 142
A phage display vector optimized for the generation of human antibody combinatorial libraries and the molecular cloning of monoclonal antibody fragments 141
A Biologically-validated HCV E1E2 Heterodimer Structural Model 141
Cell-to-cell spread-blocking activity is extremely limited in the sera of HSV-1 and HSV-2 infected subjects 140
Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: Epitope definition and implications in risk stratification of patients under natalizumab therapy 139
Interferon-β 1a inhibits SARS-CoV-2 in vitro when administered after virus infection 139
A Human Monoclonal Antibody with Neutralizing Activity against Highly Divergent Influenza Subtypes 138
Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro 138
A spatial multi-scale fluorescence microscopy toolbox discloses entry checkpoints of SARS-CoV-2 variants in Vero E6 cells 135
Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19 135
ACOD1 deficiency offers protection in a mouse model of diet-induced obesity by maintaining a healthy gut microbiota 134
A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses 132
Antibiotic appropriateness for Gram-negative bloodstream infections: impact of infectious disease consultation 129
Mechanisms of Hepatitis C Virus Escape from Vaccine-Relevant Neutralizing Antibodies 129
Cardiac implantable electronic device infections: impact of initiation of antimicrobial treatment before or after device removal on microbiological yield 128
Heparin Inhibits Cellular Invasion by SARS-CoV-2: Structural Dependence of the Interaction of the Spike S1 Receptor-Binding Domain with Heparin 127
Analysis of the faecal microbiome during analytical treatment interruption in people with chronic HIV infection and long-lasting virological suppression (APACHE study) 124
A potential role for monoclonal antibodies in prophylactic and therapeutic treatment of influenza 122
ANTI-HIV-1 RESPONSE ELICITED IN RABBITS BY ANTI-IDIOTYPE MONOCLONAL ANTIBODIES MIMICKING THE CD4-BINDING SITE ON GP120 122
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases 121
Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules 119
Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections 119
Single spike mutation differentiating XBB.1 and XBB.1.5 enhances SARS-CoV-2 cell-to-cell transmission and facilitates serum-mediated enhancement 118
A new case of Echovirus 11 neonatal fulminant hepatitis involving male twins in a Northern Italy Tertiary University Hospital: Insight on a possible immunological clue 117
Lower nasopharyngeal viral load during the latest phase of COVID-19 pandemic in a Northern Italy University Hospital 117
The efficacy of ultraviolet light-emitting technology against coronaviruses: a systematic review 117
Smallpox vaccination-elicited antibodies cross-neutralize 2022-Monkeypox virus Clade II 116
Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes 113
Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection 111
Differential composition of vaginal microbiome, but not of seminal microbiome, is associated with successful intrauterine insemination in couples with idiopathic infertility: A prospective observational study 110
Acute respiratory distress in a neutropenic febrile patient after hematopoietic cell transplantation 109
A closer look at prion strains: Characterization and important implications 109
JC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes? 109
Neutralization Interfering Antibodies: a "Novel" Mechanism of Humoral Immune Mutiny and Viral Evasion? 108
A case of psoriatic arthritis triggered by SARS-CoV-2 infection 108
IN VIVO PROTECTION CONFERRED BY HUMAN MONOCLONAL ANTIBODY DIRECTED AGAINST HSV-1 AND 2 106
Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols 106
Broadly neutralizing anti-influenza human monoclonal antibodies and their possible role in predictive medicine 104
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein 104
Anti-HIV-1 response elicited in rabbits by anti-idiotype monoclonal antibodies mimicking the CD4-binding site 103
Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge 103
Heterosubtypic protection conferred by the human monoclonal antibody PN-SIA28 against influenza A virus lethal infections in mice 102
A novel expression vector for production of epitope-tagged recombinant Fab-fragment in bacteria 102
Proper Selection of In Vitro Cell Model Affects the Characterization of the Neutralizing Antibody Response against SARS-CoV-2 100
Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials 100
IFCC interim guidelines on biochemical/hematological monitoring of COVID-19 patients 99
JN.1 variants circulating in Italy from October 2023 to April 2024: genetic diversity and immune recognition 98
An outbreak caused by multidrug-resistant OXA-58-positive Acinetobacter baumannii in an intensive care unit in Italy 98
Antibiotic resistance among sexually transmitted infections: perspectives from clinical practice 96
Harmonization of six quantitative SARS-CoV-2 serological assays using sera of vaccinated subjects 96
Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects 95
Adjuvant role of SeptiFast to improve the diagnosis of sepsis in a large cohort of hematological patients 95
Answer to February 2019 Photo Quiz: Neurological Symptoms in a 74-Year-Old Diabetic Woman Admitted to the Emergency Room 94
Genetic characterization of Klebsiella pneumoniae carbapenemase -producing Klebsiella pneumoniae isolates with different susceptibility to ceftazidime/avibactam in patients with blood-stream infections 93
Natural Flavonoid Derivatives Have Pan-Coronavirus Antiviral Activity 93
Global and local envelope protein dynamics of hepatitis C virus determine broad antibody sensitivity 92
Characterization of a lineage c.36 sars-cov-2 isolate with reduced susceptibility to neutralization circulating in lombardy, italy 92
Antigen-driven evolution of B lymphocytes in coronary atherosclerotic plaques 91
Analysis of the Enteric Microbiome: First Tentative Steps Towards a Comprehensive Work-up of Prostate Cancer? 91
Identification of a novel mutation involved in colistin resistance in Klebsiella pneumoniae through Next-Generation Sequencing (NGS) based approaches 90
Characterization of two human monoclonal anti-E2/HCV antibodies for potential application in prevention and treatment of HCV infection 90
Epitope mapping by epitope excision, hydrogen/deuterium exchange, and peptide-panning techniques combined with in silico analysis 90
Dual-Domain Reporter Approach for Multiplex Identification of Major SARS-CoV-2 Variants of Concern in a Microarray-Based Assay 90
Clinical characterization and whole genome sequence-based typing of two cases of endophthalmitis due to Listeria monocytogenes 89
Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines 89
Role and potential therapeutic use of antibodies against herpetic infections 89
Synergistic neutralization of HCV by two broadly neutralizing human monoclonal antibodies 89
IFCC interim guidelines on rapid point-of-care antigen testing for SARS-CoV-2 detection in asymptomatic and symptomatic individuals 88
Microbiome Markers are Early Predictors of Acute GvHD in Allogeneic Hematopoietic Stem Cell Transplant recipients 87
Circulating SARS-CoV-2 variants in Italy, October 2020–March 2021 86
Characterization of epitopes recognized by monoclonal antibodies: experimental approaches supported by freely accessible bioinformatic tools 85
Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro 85
HCV E2 core structures and mAbs: something is still missing 84
Sex-specific Alterations in the Urinary and Tissue Microbiome in Therapy-naïve Urothelial Bladder Cancer Patients 84
Viral Respiratory Pathogens and Lung Injury 84
Molecular characterization of the human neutralizing response against hepatitis C virus and its role in the prediction of the infection outcome 84
Broadly neutralizing human monoclonal antibodies: a novel resource against influenza viruses 83
Coronaviridae and SARS-associated coronavirus strain HSR1 82
Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020 78
SARS-CoV-2 detection in primary thyroid sarcoma: coincidence or interaction? 77
Unveiling the role of PUS7-mediated pseudouridylation in host protein interactions specific for the SARS-CoV-2 RNA genome 77
Virus-induced preferential antibody gene-usage and its importance in humoral autoimmunity 77
Very high SARS-CoV-2 load at the emergency department presentation strongly predicts the risk of admission to the intensive care unit and death 77
Reply to: Hultström et al., Genetic determinants of mannose-binding lectin activity predispose to thromboembolic complications in critical COVID-19. Mannose-binding lectin genetics in COVID-19 76
HUMAN MONOCLONAL ANTIBODY ENDOWED WITH ANTI-HSV-1 AND -2 ACTIVITY STRONGLY INHIBITS VIRUS REPLICATION 76
Monoclonal antibodies isolated from human B cells neutralize a broad range of H1 subtype influenza A viruses including swine-origin Influenza virus (S-OIV) 76
Molecular diagnosis of sepsis in neutropenic patients with haematological malignancies 76
Interferon β-1a (IFNβ-1a) in COVID-19 patients (INTERCOP): study protocol for a randomized controlled trial 76
Phage display-based strategies for cloning and optimization of monoclonal antibodies directed against human pathogens 75
Type III interferons disrupt the lung epithelial barrier upon viral recognition 75
Totale 11.642
Salva come PNG Salva come JPEG
Categoria #
all - tutte 94.227
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 94.227
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022112 0 0 0 29 13 7 13 9 4 10 6 21
2022/20231.082 350 259 98 15 22 127 62 65 49 7 14 14
2023/2024756 27 40 101 92 53 149 34 70 9 23 42 116
2024/20252.998 314 65 68 111 124 240 434 367 494 301 237 243
2025/20269.379 692 716 760 1.319 731 327 754 674 2.493 444 204 265
2026/20272.153 367 494 524 768 0 0 0 0 0 0 0 0
Totale 16.705